Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Endocrinology · Pituitary Neuroendocrine Tumor

Is a PitNET (Pituitary Neuroendocrine Tumor) Brain Cancer?

At a Glance

A pituitary neuroendocrine tumor (PitNET) is usually not brain cancer because it typically does not spread to distant organs. It can still be serious if it produces excess hormones, presses on nearby structures, grows into local tissue, or returns after treatment.

Hearing that your doctor found a “neuroendocrine tumor” can be terrifying, but it is important to know exactly what this means: a pituitary neuroendocrine tumor (PitNET) is almost never brain cancer [1][2].

The name PitNET usually describes a non-metastatic tumor of the pituitary gland [3]. It is not the same as a malignant cancer arising in the brain tissue itself, but it can still be a medically serious condition that requires treatment because it produces excess hormones or affects nearby structures [4][5].

Understanding the Pituitary Gland and the Name Change

To understand the diagnosis, it helps to know where the tumor is located. The pituitary is a small, pea-sized gland that sits at the base of the skull, just below the brain, and acts as the “master control center” for your body’s hormones [6]. Because it sits near important structures like the optic nerves (which control vision) and the cavernous sinus (a major blood vessel pathway), a growing tumor can cause problems even if it is not cancer [4][7].

The term “PitNET” is a relatively new medical classification [1]. In 2022, the World Health Organization (WHO) updated its naming guidelines, though many clinicians still use the older term, pituitary adenoma [8][9]. Historically, the word “adenoma” implied a completely harmless glandular growth. However, experts recognized that pituitary tumors exist on a spectrum [1][10]. The name “PitNET” better reflects two facts:

  1. Cell Origin: The tumor comes from neuroendocrine cells, which receive nerve signals and release hormones [2]. In Cushing disease, these specific cells produce too much ACTH (adrenocorticotropic hormone) [11][12].
  2. Behavior Spectrum: While usually non-metastatic, some PitNETs can grow into nearby tissues (local invasion) or have a higher chance of returning after surgery [4][10].

Benign vs. Malignant Behavior

In oncology, a malignant cancer (pituitary carcinoma) is generally defined by its ability to spread, or metastasize, to distant parts of the body (such as the liver or spine) [3][13]. This is exceptionally rare in pituitary tumors [13].

However, just because a PitNET does not spread to distant organs does not mean it is harmless. A non-metastatic tumor can still behave aggressively by invading the cavernous sinus, pressing on the optic nerves, or interfering with your normal pituitary function [4][7].

What This Means for Your Treatment

When you have a PitNET causing Cushing disease, the most immediate danger comes from the tumor forcing your adrenal glands to pump out too much cortisol [5][14]. Left untreated, chronic cortisol excess can cause severe complications, including high blood pressure, diabetes, blood clots, bone loss, and mood changes [15].

Transsphenoidal surgery (removing the tumor through the nose) is usually the first-line treatment, aiming to remove the source of the excess ACTH and achieve remission [16][17]. However, surgery is not a guaranteed cure. Sometimes, a tumor cannot be fully removed, or the Cushing disease persists or recurs later, requiring medication, radiation, or repeat surgery [18][19].

A Critical Note on Post-Surgery Safety:
If surgery is successful at removing the PitNET, your body’s cortisol levels will drop dramatically because your normal pituitary and adrenal glands have been suppressed by the tumor [15][20]. This creates a temporary, but serious, condition called adrenal insufficiency [15].

To keep you safe, your endocrinologist will prescribe a steroid replacement medication (like hydrocortisone) while your body slowly recovers its natural ability to make cortisol [21]. You will be given strict “sick-day rules” explaining how to increase your steroid dose if you get a fever, vomit, or face significant physical stress [15]. Never stop taking these prescribed steroids on your own, and ensure you understand exactly when to seek urgent medical attention [15].

Following treatment, you will need long-term monitoring by an endocrinologist [22]. This includes blood and urine tests to ensure your cortisol remains stable, tests to check your other pituitary hormones, and follow-up MRIs to watch for any signs that the tumor might be growing back [19][23].

Common questions in this guide

Is a PitNET considered brain cancer?
Usually not. A PitNET begins in the pituitary gland and typically does not spread to distant organs; pituitary carcinoma, which does spread, is exceptionally rare. Even without distant spread, a PitNET can be serious if it makes excess hormones, grows into nearby tissue, or affects vision.
Why do doctors call it a PitNET instead of a pituitary adenoma?
PitNET is a newer name reflected in World Health Organization classification updates, while many clinicians still use pituitary adenoma. The newer term emphasizes that the tumor comes from hormone-producing neuroendocrine cells and can have a range of behavior, including local growth or recurrence.
Can a PitNET cause serious problems even if it is not cancer?
Yes. A PitNET can press on the optic nerves, grow into nearby structures such as the cavernous sinus, or disrupt normal pituitary hormones. If it causes Cushing disease, excess cortisol can lead to high blood pressure, diabetes, blood clots, bone loss, and mood changes.
What is usually the first treatment for a PitNET that causes Cushing disease?
Transsphenoidal surgery, which removes the tumor through the nose, is usually the first treatment to remove the source of excess ACTH and aim for remission. If the tumor cannot be fully removed or the disease persists or returns, medication, radiation, or another operation may be considered.
Why might I need hydrocortisone after PitNET surgery?
After successful surgery, cortisol levels can fall sharply because the body's normal cortisol system has been suppressed by the tumor. This can cause temporary adrenal insufficiency, so hydrocortisone replacement and sick-day instructions may be needed while recovery occurs; prescribed steroids should not be stopped without medical guidance.
What follow-up is needed after PitNET treatment?
Long-term follow-up usually includes blood and urine tests for cortisol, checks of other pituitary hormones, and repeat MRI scans. An endocrinologist uses these results to watch for persistent hormone problems, adrenal recovery, or tumor regrowth.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my tumor a microadenoma or a macroadenoma, and did my MRI show any signs that it has grown into nearby structures like the cavernous sinus?
  2. 2.What is the expected remission rate for tumors with my specific pathology and imaging characteristics?
  3. 3.If surgery does not completely remove the tumor or if my cortisol levels remain high, what is our next step for treatment?
  4. 4.What will my steroid replacement (hydrocortisone) plan be immediately after surgery, and what are my "sick-day" rules for adjusting the dose if I become ill?
  5. 5.What is the long-term plan for monitoring my hormone levels (including other pituitary hormones) and scheduling repeat MRIs?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can You Have Cushing Disease With a Normal Brain MRI?Do Cushing Disease Symptoms Go Away After Treatment?How Long Does a Cortisol Crash Last After Cushing Surgery?Is It PCOS or Cushing's? How to Tell the DifferenceIs Cushing's Disease Hereditary or Genetic? Family RiskCushing Disease Surgery Fails: What Are My Options?What Is Cortisol Legacy After Cushing Disease Remission?What Is Cyclical Cushing Disease and How Is It Diagnosed?What Is IPSS? Is Inferior Petrosal Sinus Sampling Painful?Cushing Disease vs Cushing Syndrome: What's the Difference?What Is the Cushing Disease Recurrence Rate After Remission?What Kind of Doctor Treats Cushing Disease? Care TeamWhy Are Cushing Tests Done at Night or Over 24 Hours?

References

References (23)
  1. 1

    From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

    Asa SL, Casar-Borota O, Chanson P, et al.

    Endocrine-related cancer 2017; (24(4)):C5-C8 doi:10.1530/ERC-17-0004.

    PMID: 28264912
  2. 2

    Advancements in Molecular Diagnosis and Pharmacotherapeutic Strategies for Invasive Pituitary Adenomas.

    Xu D, Wang L, Zheng M

    Immunity, inflammation and disease 2024; (12(12)):e70098 doi:10.1002/iid3.70098.

    PMID: 39688352
  3. 3

    Overview of the 2022 WHO Classification of Pituitary Tumors.

    Asa SL, Mete O, Perry A, Osamura RY

    Endocrine pathology 2022; (33(1)):6-26 doi:10.1007/s12022-022-09703-7.

    PMID: 35291028
  4. 4

    Transformation of Lactotroph Pituitary Adenoma to Metastatic Pituitary Carcinoma: A Case Report.

    Christensen K, Mrvoljak M, Njoku CL, et al.

    Cureus 2025; (17(10)):e95326 doi:10.7759/cureus.95326.

    PMID: 41293361
  5. 5

    Cushing's disease: pathobiology, diagnosis, and management.

    Lonser RR, Nieman L, Oldfield EH

    Journal of neurosurgery 2017; (126(2)):404-417 doi:10.3171/2016.1.JNS152119.

    PMID: 27104844
  6. 6

    Pituitary-Tumor Endocrinopathies.

    Melmed S

    The New England journal of medicine 2020; (382(10)):937-950 doi:10.1056/NEJMra1810772.

    PMID: 32130815
  7. 7

    Thin-Slice Pituitary MRI with Deep Learning-based Reconstruction: Diagnostic Performance in a Postoperative Setting.

    Kim M, Kim HS, Kim HJ, et al.

    Radiology 2021; (298(1)):114-122 doi:10.1148/radiol.2020200723.

    PMID: 33141001
  8. 8

    Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

    Ho K, Fleseriu M, Kaiser U, et al.

    Journal of the Endocrine Society 2021; (5(3)):bvaa205 doi:10.1210/jendso/bvaa205.

    PMID: 33604494
  9. 9

    Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective.

    Liu X, Wang R, Li M, Chen G

    Translational cancer research 2021; (10(4)):1916-1920 doi:10.21037/tcr-20-3446.

    PMID: 35116513
  10. 10

    Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?

    Lee CH

    Brain tumor research and treatment 2023; (11(3)):173-176 doi:10.14791/btrt.2023.0015.

    PMID: 37550816
  11. 11

    A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.

    Woo CS, Ho RS, Ho G, et al.

    Frontiers in endocrinology 2024; (15()):1368944 doi:10.3389/fendo.2024.1368944.

    PMID: 38756997
  12. 12

    Challenges in the Diagnosis of Pituitary Neuroendocrine Tumors.

    Asa SL

    Endocrine pathology 2021; (32(2)):222-227 doi:10.1007/s12022-021-09678-x.

    PMID: 33866514
  13. 13

    Rapid Growth of a Lung Cancer Metastasis to a Pituitary Neuroendocrine Tumor: A Case Report and Literature Review.

    Kawabata T, Nishida Y, Oyama T, et al.

    NMC case report journal 2025; (12()):427-433 doi:10.2176/jns-nmc.2024-0227.

    PMID: 41112428
  14. 14

    Advances in Molecular Pathophysiology and Targeted Therapy for Cushing's Disease.

    Takayasu S, Kageyama K, Daimon M

    Cancers 2023; (15(2)) doi:10.3390/cancers15020496.

    PMID: 36672445
  15. 15

    Current best practice in the management of patients after pituitary surgery.

    Prete A, Corsello SM, Salvatori R

    Therapeutic advances in endocrinology and metabolism 2017; (8(3)):33-48 doi:10.1177/2042018816687240.

    PMID: 28377801
  16. 16

    Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series.

    Serban AL, Del Sindaco G, Sala E, et al.

    Journal of endocrinological investigation 2020; (43(5)):631-639 doi:10.1007/s40618-019-01151-1.

    PMID: 31773581
  17. 17

    Cushing Syndrome: A Review.

    Reincke M, Fleseriu M

    JAMA 2023; (330(2)):170-181 doi:10.1001/jama.2023.11305.

    PMID: 37432427
  18. 18

    Outcome of Microscopic Transsphenoidal Surgery in Cushing Disease: A Case Series of 96 Patients.

    Shirvani M, Motiei-Langroudi R, Sadeghian H

    World neurosurgery 2016; (87()):170-5.

    PMID: 26704208
  19. 19

    Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study.

    Ragnarsson O, Olsson DS, Papakokkinou E, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(6)):2375-2384 doi:10.1210/jc.2018-02524.

    PMID: 30715394
  20. 20

    Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.

    Stolyarov Y, Mirocha J, Mamelak AN, Ben-Shlomo A

    Pituitary 2018; (21(1)):41-49 doi:10.1007/s11102-017-0845-3.

    PMID: 29143885
  21. 21

    Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

    Prete A, Paragliola RM, Bottiglieri F, et al.

    Endocrine 2017; (55(3)):969-980 doi:10.1007/s12020-016-1007-5.

    PMID: 27395418
  22. 22

    Cushing Disease: Medical and Surgical Considerations.

    Bray DP, Rindler RS, Dawoud RA, et al.

    Otolaryngologic clinics of North America 2022; (55(2)):315-329 doi:10.1016/j.otc.2021.12.006.

    PMID: 35256173
  23. 23

    Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case.

    Armstrong SA, Tavakoli S, Shah I, et al.

    Journal of neurosurgery. Case lessons 2023; (6(22)).

    PMID: 38011690

This page explains why most PitNETs are not considered brain cancer and summarizes treatment and follow-up for educational purposes only; it does not replace medical advice. Your endocrinologist and neurosurgeon can interpret your MRI, hormone tests, and individual risks.

Get notified when new evidence is published on Cushing disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.